A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Conditions:   Sarpogrelate;   Blood Viscosity;   Peripheral Arterial Disease;   Coronary Artery Disease Interventions:   Drug: Sarpogrelate Sustained Release/Aspirin;   Drug: Aspirin Sponsor:   Yuhan Corporation Recruiting

Source: ClinicalTrials.gov - February 16, 2023 Category: Research Source Type: clinical trials